These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21946473)

  • 1. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
    Cifuentes C; Aguilar-de-Leyva A; Rajabi-Siahboomi AR; Caraballo I
    Acta Pharm; 2013 Mar; 63(1):115-29. PubMed ID: 23482317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets.
    Novak SD; Kuhelj V; Vrečer F; Baumgartner S
    Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    AAPS PharmSciTech; 2010 Jun; 11(2):558-62. PubMed ID: 20352536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.
    Castellanos Gil E; Iraizoz Colarte A; Bataille B; Brouillet F; Caraballo I
    Eur J Pharm Sci; 2009 Nov; 38(4):312-9. PubMed ID: 19666114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Jan; 41(1):70-8. PubMed ID: 24134563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
    Caraballo I
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.